Finding an effective antidepressant can be as hit-or-miss as finding a drinkable cappuccino in a strip mall…or a date-able date on Tinder. And we’re not being flip. “Part of the challenge of ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

Pharmacogenomics, the study of how genetic variations influence medication response, is one of the most widely used forms of precision medicine. Understanding a patient’s unique genetic makeup helps ...

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...

PGx testing can help increase the quality of patient care and decrease adverse drug events, healthcare costs, and hospitalization for patients who undergo testing. Genemarkers remains committed to ...

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...

STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics ...

This viewpoint is to provide and clarify details regarding the business article published on July 3, headlined “Dr. Julie Wharam hopes to bring pharmacogenomics to mainstream Grand Forks region.” Do ...

The struggles facing long-term care are numerous and well-documented. Providers, facilities, and families are constantly trying to find solutions to help improve patient care and staffing burdens.

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc.